↓ Skip to main content

Serologic markers of viral infection and risk of non‐Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore

Overview of attention for article published in International Journal of Cancer, April 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serologic markers of viral infection and risk of non‐Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore
Published in
International Journal of Cancer, April 2018
DOI 10.1002/ijc.31385
Pubmed ID
Authors

Bryan A. Bassig, Martina Willhauck‐Fleckenstein, Xiao‐Ou Shu, Woon‐Puay Koh, Yu‐Tang Gao, Mark P. Purdue, Yong‐Bing Xiang, Jennifer Adams‐Haduch, Renwei Wang, Nicole Brenner, Tim Waterboer, Angelika Michel, Bu‐Tian Ji, H. Dean Hosgood, Charles S. Rabkin, Gong Yang, Jason Y.Y. Wong, Jinming Zhang, Wei Hu, Wei Jie Seow, Wong‐Ho Chow, Michael Pawlita, Wei Zheng, Jian‐Min Yuan, Qing Lan, Nathaniel Rothman

Abstract

Incidence rates of non-Hodgkin lymphoma (NHL) and distributions of certain viruses differ between East Asian and Western populations. There are limited data on associations between serologic markers of multiple viral infections in pre-diagnostic blood and NHL risk in East Asians. We conducted a nested case-control study of 214 NHL cases and 214 matched controls from three population-based prospective cohorts in Shanghai and Singapore. Antibodies against antigens from herpesviruses, Hepatitis B (HBV) and C (HCV) virus, and polyomaviruses were measured in plasma or serum using fluorescent bead-based multiplex assays. Conditional logistic regression was used to evaluate associations between antibody levels and NHL risk. An increased risk of NHL was observed for higher compared to lower EA-D (Odds Ratio (OR) = 2.04, 95% Confidence Interval (CI) = 1.10-3.81; ptrend= 0.005) and ZEBRA (OR = 2.17, 95% CI = 0.96-4.89; ptrend= 0.008) Epstein-Barr Virus (EBV) antibodies, as well as for antibody seropositivity against the IE1A human herpesvirus-6 (HHV-6) antigen (OR = 1.85, 95% CI = 1.04-3.29). An increased NHL risk was also observed for higher compared to lower antibodies against the HBV-HBc and HBe antigens. An increased risk of NHL in relation to EBV and HBV infection in East Asians is consistent with findings in several studies of Western populations, suggesting similar viral risk factors for NHL in these diverse populations with distinct patterns of NHL. The association between HHV-6 antibodies and NHL has not previously been reported in a prospective study in this population and will require replication. This article is protected by copyright. All rights reserved.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 16%
Other 4 13%
Student > Master 3 9%
Student > Bachelor 2 6%
Professor 2 6%
Other 5 16%
Unknown 11 34%
Readers by discipline Count As %
Medicine and Dentistry 6 19%
Biochemistry, Genetics and Molecular Biology 2 6%
Immunology and Microbiology 2 6%
Psychology 2 6%
Economics, Econometrics and Finance 2 6%
Other 7 22%
Unknown 11 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 January 2019.
All research outputs
#15,432,895
of 24,464,848 outputs
Outputs from International Journal of Cancer
#9,677
of 12,075 outputs
Outputs of similar age
#191,814
of 333,880 outputs
Outputs of similar age from International Journal of Cancer
#66
of 125 outputs
Altmetric has tracked 24,464,848 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,075 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,880 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.